Enamine is a scientifically driven integrated drug discovery contract research organization (CRO). We maintain the world’s largest and most reputable collections of building blocks (over screening compounds (over 4.7 million), and a vast database of synthetically feasible chemical structures —. The company offers an extensive portfolio of expertly designed libraries for hit discovery, including Diversity, Fragment, Covalent, Bioactive, and Targeted Libraries, and delivers fully Integrated Discovery Services (IDD) spanning advanced organic synthesis, library synthesis, medicinal chemistry,…
Annual Revenue$500M to $1B
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.